Rang	Name	Position
1	Dr. Neil Kumar Ph.D.	Co-Founder, CEO & Director
2	Dr. Thomas Trimarchi Ph.D.	CFO & President
3	Dr. Charles J. Homcy M.D.	Co-Founder, Chairman of Pharmaceuticals & Lead Director
4	Dr. Frank P. McCormick Ph.D.	Co-Founder, Chairman of Oncology & Director
5	Ms. Maricel M. Apuli	Chief Accounting Officer
6	Dr. Uma Sinha Ph.D.	Chief Scientific Officer
7	Dr. Richard H. Scheller Ph.D.	Chairman of Research & Development
8	Mr. Eli M. Wallace Ph.D.	Chief Scientific Officer of Oncology
9	Dr. Eric Michael David J.D., M.D., Ph.D.	Chief Executive Officer of Gene Therapy
10	Mr. Matthew Outten CPC, MBA	Chief Commercial Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	7,27%	1,03 Mrd. USD
2	Kohlberg Kravis Roberts & Co LP	6,78%	0,96 Mrd. USD
3	HHG PLC	6,74%	0,96 Mrd. USD
4	Viking Global Investors LP	6,06%	0,86 Mrd. USD
5	Farallon Capital Management, L.L.C.	4,79%	0,68 Mrd. USD
6	Vanguard Portfolio Management, LLC	4,13%	0,59 Mrd. USD
7	Vanguard Capital Management, LLC	3,97%	0,56 Mrd. USD
8	Wellington Management Company LLP	2,72%	0,39 Mrd. USD
9	State Street Corp	2,52%	0,36 Mrd. USD
10	Geode Capital Management, LLC	2,52%	0,36 Mrd. USD
11	Two Sigma Investments LLC	2,42%	0,34 Mrd. USD
12	Amvescap Plc.	2,35%	0,33 Mrd. USD
13	Aisling Capital Management LP	2,35%	0,33 Mrd. USD
14	T. Rowe Price Associates, Inc.	1,94%	0,28 Mrd. USD
15	Citadel Advisors Llc	1,92%	0,27 Mrd. USD
16	D. E. Shaw & Co LP	1,86%	0,26 Mrd. USD
17	Frazier Life Sciences Management, L.P.	1,76%	0,25 Mrd. USD
18	Polar Capital Holdings PLC	1,29%	0,18 Mrd. USD
19	Franklin Templeton Inc	1,25%	0,18 Mrd. USD
20	FMR Inc	1,20%	0,17 Mrd. USD